In this webinar, Kristie Johnson, PhD, D(ABMM), F(AAM), and Kimberly Claeys, PharmD, PhD, share preliminary data from a recent study evaluating the potential benefits of decentralizing rapid phenotypic antimicrobial susceptibility testing in managing patients with Gram-negative bloodstream infections.
This webinar is sponsored by Q-Linea.